Tuesday, November 29, 2011 3:51:21 PM
Nov 23, 2011
OTC Disclosure & News Service
Charles Town, WV -
Company to use clinical trials to further document product’s value
Charles Town, WV – November 23, 2011 - ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) today announced plans to begin recruitment of physicians and subjects for clinical trials of its nutritional supplement, ReStore.
The ReStore formula, an all-natural, sugar-free gluten free energy supplement, under license, has been successfully used in the treatment and elimination of sub-clinical depression. One of its unique and unexpected beneficial effects is a marked increase in energy. ReBuilder Medical Technologies, Inc. is marketing ReStore as a nutritional supplement and energy drink that’s both safe and beneficial for diabetics and those suffering from the depressive effects of chronic pain, particularly the symptoms of diabetic peripheral neuropathy.
“Diabetics often suffer from vitamin B deficiencies, especially Vitamin B12,” said David B. Phillips, Ph.D., CEO of ReBuilder Medical Technologies, Inc. “ReStore has a full complement of B vitamins to support the health of diabetic’s nerve cells, and this results in better communication between the brain and the voluntary muscles. By increasing the efficiency of these connections, the patient receives more accurate feedback from his extremities and an increase in muscle fiber recruitment, so that it takes less expenditure of energy to move. All this translates into better mood and more energy.”
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM